ACQUISITION OF THE MEDICINE RISDIPLAM ORAL SOLID POWDER 0.75 MG/ML FOR THE BACA ORTIZ PEDIATRIC HOSPITAL

This tender concerns the procurement of Risdiplam, an oral solid powder medication with a concentration of 0.75 mg/mL, specifically for the Baca Ortiz Pediatric Hospital. The contract, identified by process code RE-PU-HBO-2025-001-40576, falls under the modality of unique goods and services. The primary requirement is the acquisition of Risdiplam oral solid powder, presented in a box containing one 80 mL bottle along with a device. The estimated value for this item is USD 369,391.20. The contracting entity is the Baca Ortiz Pediatric Hospital, a key healthcare institution serving pediatric patients. Eligibility criteria for bidders include meeting specific qualification parameters, demonstrating compliance with technical specifications, and possessing both general and specific experience relevant to the supply of pharmaceutical products. This procurement is crucial for ensuring the availability of essential medication for the hospital's specialized patient population. The Baca Ortiz Pediatric Hospital seeks to secure a reliable supply of this vital drug through a transparent and competitive bidding process, adhering to established procurement regulations. Potential suppliers are expected to provide comprehensive documentation and meet all stipulated requirements to be considered for this contract.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 369,391.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.